BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szymczyk J, Sluzalska KD, Materla I, Opalinski L, Otlewski J, Zakrzewska M. FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance. Cancers (Basel) 2021;13:5796. [PMID: 34830951 DOI: 10.3390/cancers13225796] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Bianchi A, von Deimling M, Pallauf M, Yanagisawa T, Kawada T, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Majdoub M, Motlagh RS, Pradere B, Karakiewicz PI, Cerruto MA, Antonelli A, Shariat SF. Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond. Expert Opinion on Pharmacotherapy 2022. [DOI: 10.1080/14656566.2022.2150966] [Reference Citation Analysis]
2 Szymczyk J, Sochacka M, Chudy P, Opalinski L, Otlewski J, Zakrzewska M. FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms. Front Oncol 2022;12:1011762. [DOI: 10.3389/fonc.2022.1011762] [Reference Citation Analysis]
3 Pagano K, Longhi E, Molinari H, Taraboletti G, Ragona L. Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches. Int J Mol Sci 2022;23:10860. [PMID: 36142770 DOI: 10.3390/ijms231810860] [Reference Citation Analysis]
4 Jia X, Xin M, Xu J, Xiang X, Li X, Jiao Y, Wang L, Jiang J, Pang F, Zhang X, Zhang J. Inhibition of autophagy potentiates the cytotoxicity of the irreversible FGFR1-4 inhibitor FIIN-2 on lung adenocarcinoma. Cell Death Dis 2022;13:750. [PMID: 36042213 DOI: 10.1038/s41419-022-05201-0] [Reference Citation Analysis]
5 Ranieri D, French D, Persechino F, Guttieri L, Torrisi MR, Belleudi F. The FGFR2c/PKCε Axis Controls MCL-1-Mediated Invasion in Pancreatic Ductal Adenocarcinoma Cells: Perspectives for Innovative Target Therapies. Biomedicines 2022;10:1652. [DOI: 10.3390/biomedicines10071652] [Reference Citation Analysis]
6 Ornitz DM, Itoh N. New developments in the biology of fibroblast growth factors. WIREs Mech Dis 2022;14:e1549. [PMID: 35142107 DOI: 10.1002/wsbm.1549] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
7 Che P, Jiang S, Zhang W, Zhu H, Hu D, Wang D. A comprehensive gene expression profile analysis of prostate cancer cells resistant to paclitaxel and the potent target to reverse resistance. Hum Exp Toxicol 2022;41:9603271221129854. [PMID: 36165000 DOI: 10.1177/09603271221129854] [Reference Citation Analysis]